Verified peer comparison
Decent Holding vs GT Biopharma Financial Comparison
Direct answer
Decent Holding and GT Biopharma are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Decent Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Decent Holding Revenue
- 12,949,345 USD
- GT Biopharma Revenue
- 0 USD
- Decent Holding Operating income
- -138,576 USD
- GT Biopharma Operating income
- -12,422,000 USD